Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Behçet's disease (BD) is a type of inflammatory disorder affecting multiple parts of the body. Apremilast is a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4). The diminished inflammatory response by PDE4 inhibition is reported to offer a therapeutic benefit and clinical improvement in BD.
Materials And Methods: A systematic electronic literature search was conducted following PRISMA guidelines. PubMed/MEDLINE, Google Scholar, and EBSCOhost were searched from January 2014 to March 2024 in English language only. Eligible studies included clinical patient studies that evaluated the effectiveness and safety of apremilast on oral ulcers in BD.
Results: Four articles included in the qualitative analysis stated that apremilast resulted in a significant reduction in oral ulcers even in patients refractory to several systemic drugs. Risk of bias assessment indicated low to moderate bias in all the studies.
Limitation: Lack of sufficient literature, with different study designs preventing meta-analysis.
Conclusion: Apremilast has proved to be effective and safe in the management of oral ulcers in BD, indicating its use as a drug of choice. Further research with a longer follow-up period and an active comparator is required to determine its efficacy over long periods of administration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4103/idoj.idoj_779_24 | DOI Listing |
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12419702 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Retrospective analysis of common diseases in pediatric oral emergency patients of Ningbo.
Front Dent Med
August 2025
Department of Otorhinolaryngology Head and Neck Surgery, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, China.
Background: With the increase in the resident population and the number of children in Ningbo, as well as the growing demand for oral health care, the number of children's dental emergencies has been increasing year by year. This trend not only increases the pressure on medical resources, but also puts higher demands on the level of children's oral emergency care. In order to better guide the diagnosis and treatment of common and frequent diseases in paediatric oral emergency care, and to improve the efficiency of the use of medical resources.
View Article and Find Full Text PDFMicrobiological mechanisms of oral mucosal disease: oral-intestinal crosstalk and probiotic therapy.
Front Oral Health
August 2025
School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Balance of the oral-intestinal axis microbiota is essential for maintaining oral mucosal health. The occurrence of oral disease is closely linked to the microbiota, this disorder is closely related to the pathogenesis of oral mucosal diseases, such as oral lichen planus, recurrent aphthous ulcer, oral candidiasis and squamous-cell carcinoma. As a microorganism that is beneficial to host health, probiotics can show multi-dimensional therapeutic effects in oral mucosal diseases by targeting and regulating the immune microenvironment of the oral mucosa, inhibiting the colonization of pathogenic bacteria and repairing the barrier function.
View Article and Find Full Text PDFFamotidine-loaded chitosan hybridized fibroin nanoparticles exhibit outstanding efficacy in ameliorating peptic ulcer.
Int J Biol Macromol
September 2025
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Cairo, 11829, Egypt.
Famotidine (FMD) is an H₂-receptor antagonist with limited oral bioavailability and a short plasma half-life (2.5-4 h). Silk fibroin-chitosan nanoparticles (FBN-CS-NPs) represent a novel nanocarrier approach for treating peptic ulcers, combining biocompatibility, mucoadhesiveness, and pH-sensitive release.
View Article and Find Full Text PDFExploring topical atorvastatin hyalurosomal gel as an adjuvant for reducing systemic corticosteroid dosage: a randomized clinical trial in severe oral lichen planus patients.
Drug Deliv Transl Res
September 2025
Pharmaceutics and Drug Manufacturing Department, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Cairo, 11571, Egypt.
Oral lichen planus (OLP) is a chronic inflammatory disorder with limited topical treatment options and long-term corticosteroid dependency. This study investigates a novel atorvastatin-loaded hyalurosomal gel (ATV-Hyalugel) as a topical adjuvant to reduce systemic corticosteroid use in severe OLP. The objective of the study is to develop, optimize, characterize ATV-Hyalugel and evaluate its clinical efficacy in a randomized controlled clinical trial.
View Article and Find Full Text PDFAdvances in chitosan-based materials for oral ulcer treatment.
Carbohydr Polym
November 2025
Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China. Electronic address:
Oral ulcers are a prevalent condition globally, causing significant pain and discomfort. The unique environment of the oral cavity, characterized by its humidity and dynamic nature, in conjunction with a diverse microbiome, presents challenges for traditional treatments for oral ulcers. Chitosan has emerged as a promising therapeutic agent for this condition.
View Article and Find Full Text PDF